ARIXTRA
ARIXTRA
Approved
DIN Number
02245531
Drug Class
Human
Market Date
Jul 19, 2002
Company
HC
Aspen Pharmacare Canada Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02245531
AIG Number0146781001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AX05 FONDAPARINUX
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
,
Intravenous
AHFS Classification20:12.04.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
FONDAPARINUX SODIUMActive
Strength: 2.5 MG / 0.5 ML
Monograph: FONDAPARINUX SODIUM